Ordered
alphabetically by student's last name
Lavender | Majid |
Millner | Neal | Ociepa | Samant | Smith | Umoren | Wille |
Lavoie |
McLaughlin | Mmagu | Nguyen | Reisinger | Shuman | Sun | Warren | Woody |
Madden | Michael | Mogere | Nigro | Richards | Sloofman | Teixeira | Warriner | Zilora |
Regulation of Spot14, a Gene Induced by Thyroid Hormone in Preadipocytes Marysol D. Lavander, Barbara Kwakye Safo, David Usher Department of Biological Sciences Spot14 or Thyroid hormone
responsive protein is a
transcription factor found in lipogenic tissues such as the liver,
brown and white
adipose tissues and lactating mammary glands. In previous studies, it
has been
shown that expression of Spot 14 is regulated by liver X receptor
(LXR), peroxisome proliferator-activated
receptor gamma
(PPARγ) as well as triiodo-L-thyronine (T3). There are two,
long
term goals of this study. One is to identify Spot14 target genes in
adipocytes.
Once a gene has been identified, experiments will be done to locate
Spot14’s
binding sequence. Possible target genes of Spot14 are ATP citrate lyase
(Acly),
malic enzyme supernatant (Mod1), malate dehydrogenase 1 (Mdh1),
acetyl-Coenzyme
A carboxylase alpha (Acaca), pyruvate carboxylase (Pcx), and solute
carrier
family 25 member 1 (Scl25a1). The second goal is to determine regions
of the
Spot14 promoter, which make Spot14 sensitive to cholesterol
concentration. In
this study, primers were designed to identify the proximal promoter
region of
Spot14, a region 2kb upstream of the 5’ end of the gene. Once
identified this
proximal promoter will be inserted into the expression vector pGL4
Luciferase
Reporter from Promega. Primer selection was done by utilizing the
Primer3
website to customize the forward and reverse primers for a 2kb product.
The reverse
primer region was tested along with the HindIII linker that would be
attached
to the Luciferase gene on the vector by using the NCBI Open Reading
Frame (ORF)
Finder. Once it was established that the primers worked, we ran RT-PCR
on DNA from
isolated undifferentiated fibroblast cell line 3T3-L1. Funded by
the Science and Engineering Program as a Life Science Scholar. |
Copy Number Changes in the PLP1 Region in Patients with PMD Danielle Lavoie, Karen Sperle, and Grace Hobson1 University Pelizaeus-
Merzbacher Disease (PMD) is an X-linked recessive condition that
affects the
production and function of myelin in the central nervous system. It is caused by alterations in the
proteolipid protein 1 (PLP1) gene on Xq22. These
alterations include copy number changes in the
chromosomal region
containing the gene, as well as point mutations in the gene itself. Previous research has shown that the size of
the region with copy number changes varies among PMD patients. We analyzed DNA from nine patients via
quantitative multiplex PCR to delineate the region of copy number
change in
these individuals. All of these DNAs
have duplicated regions, and five have triplications in addition to the
duplications. One patient has DNA
regions with a copy number greater than triplicated.
The size of the region of copy number change
proximal to PLP1 is variable among these patients, but eight of the
nine have
their duplications/ triplications ending in the low copy repeat (LCR)
region
distal to PLP1, suggesting a possible role for this structure in the
mechanism
by which the rearrangements were formed. Junction
fragments across duplication breakpoints were
obtained in two
patients, showing tandem head-to-tail orientation.
One patient’s DNA had a simple rearrangement
and the other had a complex rearrangement with microhomologies. One of these patients yielded the same
junctions as his affected relative, showing the familial nature of
these
rearrangements. These data support
previous research suggesting a mechanism of non-homologous end joining
in the
formation of the copy number changes. A
junction fragment involving a triplicated region is still being pursued.
Funded by Nemours
Biomedical Research
|
Shear-Induced Activation of Ras Homologous A (RhoA) GTPase Increases Actin Organization and Cellular Stiffness in Osteoblasts Gregory Madden, Weidong Yang, Manisha Malik, Elizabeth L. Adams, Department Osteoblasts respond to
mechanical
stimuli with increased intracellular signaling and gene expression that
ultimately results in bone formation, in vivo, yet skeletal
mechanosensitivity
is lost upon continued stimulation. Osteoblasts
subjected to fluid shear rapidly polymerize
the actin
cytoskeleton, forming actin stress fibers that we predict is critical
to the
loss of mechanosensitivity. Parathyroid
hormone (PTH), a calciotropic hormone that is crucial to the regulation
of bone
mass, enhances the response of bone to mechanical loading and we have
shown
that PTH reduces cellular stiffness two-fold by disruption of actin
filaments. We postulated that activation
of the Ras
homologous A (RhoA) GTPase pathway, a pathway known to promote actin
assembly
in other tissues, mediates cytoskeletal organization in response to
shear. Using Atomic Force Microscopy (AFM) to
quantify osteoblastic stiffness through stress-strain kinetics, we
found that
exposure of MC3T3-E1 osteoblasts to 12 dynes/cm2 fluid shear
for 15
min significantly increased cellular stiffness from 1.1 kPa in static,
or
non-sheared, controls to 6.0 kPa in sheared osteoblasts.
While RhoA activates
several effector
proteins, previous studies in our lab have shown that Rho-dependent
kinase
(ROCK)
regulates actin
polymerization by phosphorylating the actin severing protein, cofilin,
rendering
this protein inactive. Specific
inhibition of ROCK with Y27632 significantly attenuated the
shear-induced
increase in cellular stiffness to 2.6 kPa. Conversely,
the cell stiffness of non-sheared cells
increased to values
similar to those of sheared cells (5.2 kPa) upon addition of a RhoA
GTPase
activator, lysophosphatidic acid (LPA). These
studies suggest that fluid shear induces
increased actin organization through the activation of the RhoA-ROCK
pathway
and that the resultant changes in cell stiffness may play a role in the
decreased mechanosensitivity of osteoblasts. (Supported
by HHMI and NIH/NIAMS AR043222). |
Characterization of Voltage Sensitive Calcium Channel Subunits in MLO-Y4 Osteocyte-Like Cells Amber S. Majid, William R. Thompson, Mary C. Farach-Carson Department of Biological Sciences There are three major
types of bone cells, osteoblasts,
osteoclasts, and osteocytes. Osteocytes
are the most abundant cells in bone. While their function is not
completely understood,
osteocytes sense mechanical signals within bone. Voltage sensitive
calcium
channels (VSCC) span the cell membrane and open in response to external
stimuli
resulting in altered Ca2+ permeability.
Once inside the cell, Ca2+ acts as
a second messenger eliciting specific cellular responses.
L-type VSCCs are composed of a complex of
polypeptide units consisting of a pore-forming α1 subunit,
an
intracellular β subunit, a dimer of disulfide linked α2 and
δ
subunits, which form an extracellular auxiliary complex and a γ subunit
in some
tissues. Osteocytes have been found to
express higher levels of the T-type (Cav3.2) α1H
subunit
than the L-type (Cav1.2) α1C subunit. The remaining subunits of the T-type VSCC
have not yet been characterized in osteocytes. This
study was designed to examine the expression of L-
and T-type VSCC
subunits in an osteocytic cell line, MLO-Y4. We
found significant levels of both the α1C
subunit
transcript and the α1H subunit transcript in the MLO-Y4 cell
line. Additionally, we demonstrated the
presence of the α2δ1 subunit transcript but not
the α2δ2,
α2δ3, or α2δ4 transcripts
within
MLO-Y4 osteocytes. Continued studies
will determine if the MLO-Y4 α2δ subunits associate with α1
subunits representing L-type and/or T-type VSCCs. Characterization of
VSCC
structure within osteocytes provides a rationale to conduct
functional studies such as the role of these channels in calcium
signaling
associated with mechanotransduction. Supported by HHMI and COBRE P20 RR016458.
|
Eamon McLaughlin, Shyama Majumdar, Department of Biological Sciences When subjected
to a novel mechanical load, the skeleton will remodel to increase bone
mass to
sustain this load. Our lab has shown
that when the purinergic receptor P2X7, an
ATP-gated ion
channel, is deleted in mice, these mice exhibit a skeletal phenotype
typical of
disuse osteoporosis (paralysis, extended bed rest, or space travel) and
demonstrate
decreased mechanosensitivity to exogenous mechanical loading compared
to
normal, or wild-type mice. We have also
shown that activation of the P2X7 receptor
promotes the
uptake of large solutes such as YO-PRO1, a fluorescent dye weighing 629
daltons. We hypothesize that caveolins,
membrane proteins associated with clathrin-independent endocytosis, are
responsible for this uptake and that caveolins act to internalize P2X7
receptors to regulate their mechanical activation.
Western blot analyses of MC3T3-E1 preosteoblasts
subjected to 12 dynes/cm2 fluid shear demonstrated that
caveolin-1
was phosphorylated within 15 min of the onset of shear. Inhibition of P2X7
with Brilliant Blue G or hydrolysis of extracellular ATP with apyrase
significantly attenuated this phosphorylation event.
Stimulation of P2X7
receptors with the specific agonist, BzATP, resulted in increased
caveolin-1
phosphorylation. These data indicate
that caveolin-1 is activated in response to shear through P2X7
receptor binding and suggests that this activation may be crucial to
the
mechanosensitivity of the osteoblast. Future
studies will examine the mechanisms associated with
phosphorylation of caveolin and the role of caveolin in
mechanotransduction,
which could prove to be vital in the treatment of osteoporosis.This
project was
funded in part by a National Institute of Health INBRE grant and
NIH/NIAMS
Grant AR043222. |
Investigation of long-term effects of Nanoscale TiO2 on Murine Spermatogenesis Rowan Michael, Minghai Shao, Genevieve Griffiths, and Patricia A. Martin-DeLeon Department of Biolgical Sciences The
retention of excess residual cytoplasm (EC), loosely termed cytoplasmic
droplets, on the sperm flagellum during spermiogenesis is associated
with male
infertility in a wide variety of mammalian species, including humans.
These
abnormal structures are produced by both over-expression of
hyaluronidases and
environmental exposure to agents creating reactive oxygen species
(ROS). Nanoscale
titanium dioxide (TiO2) has been shown to form ROS when
exposed to
ultraviolet light and in aqueous suspension. The objective of this
study was to
examine the effects of nano-TiO2 in mice, specifically
relating to
EC formation and other morphological abnormalities. Mice were injected
intraperitoneally with either a control, low or high dose of nano-TiO2
for
three consecutive days. They were then sacrificed at varying intervals
after
injection, the cauda and corpus of the epididymis were minced to
extract sperm,
and the testes were removed and frozen. The sperm from mice exposed to
nano-TiO2
were then compared to the control sperm in regards to morphology,
motility,
ability to acrosome react, and mitochondrial potential. The testes were
then
sectioned and DNA was extracted and observed for any damage. To date,
there
have been no significant differences observed between sperm from mice
receiving
a control, low dose or high dose of nano-TiO2. Funded by
Howard
Hughes Medical Institute. |
Development of an In Vitro Explant Culture System for the Avian Embryonic Lung to Examine SP-A and SP-B Expression through RT-PCR and Western Blot Analysis Patricia R. Millner, Department of Biological Sciences, and Sabrina M. Brougher, Department of Biological Sciences, Fetal
lung cultured as explants, in which intercellular structural design is
kept
constant, is known to respond to certain hormones and agents that can
either
promote or inhibit the acquisition of surfactant related properties.
Our goal
was to develop an in vitro culture
system for avian lung explant tissue to examine patterns of
differential
expression of SP-A and SP-B in response to hormone culture through
RT-PCR and
Western Blot analysis. We hypothesized that we would see more
expression of
SP-A and SP-B in the DCI medium compared to the 8-bromo-cAMP + IBMX
medium, the
Dexamethasone medium, and the Waymouth medium used, because DCI is a
combination of all 3 of the other media; having multi-hormones present
in its
make-up. Fetal lung tissue was obtained on day 15 from 20 fowl embryos.
In
brief, the tissue was minced into approximately 5 micrometer increments
and
cultured as explants in a CO2 incubator; temperature was set
at 37ºC
with an atmosphere of 95% air/ 5% CO2 on a rocker platform
(3oscillations/min),
gas pressure was set at 15 psi. Explants were maintained for 1-5 days
in one of
four types of media. The media were changed daily. We have not yet
finished
Western Blot and RT-PCR analysis on the explant samples. Once we gather
results, we will be able to examine the patterns of differential
expression of
SP-A and SP-B in response to the various hormone cultures. Supported by
NIH
grant 2 P20 RR016472-07 under the INBRE Program of the
|
The PPARα Agonist, Fenofibrate, Increases
MUC1
Expression in T47D Breast Cancer Cells Ninety percent of all
breast cancers overexpress the high molecular weight,
cell surface mucin, MUC1. MUC1 is a
multifunctional cell surface component that protects normal and tumor
cell
surfaces from infection, enzymatic attack and immune responses as well
as
participates in several intracellular signal transduction pathways. Peroxisome Proliferator-Activated Receptors
(PPARs) are ligand-activated transcription factors that enter the
nucleus,
heterodimerize with retinoid X receptor (RXR), and bind to PPAR
response
elements. Recent studies have shown that
PPAR agonists display anti-cancer effects, and may modulate
progesterone
responses. We hypothesized that
fenofibrate, a PPARα agonist, antagonizes progesterone-stimulated MUC1
expression in T47D breast cancer cells. We
confirmed the presence of the subunits of PPAR and RXR
by
RT-PCR. After culture and treatment, the
T47D cells were lysed, and the proteins were detected by Western
Blotting. However, fenofibrate increased
MUC1
expression in T47D breast cancer cells. It
is likely that activation of PPARα causes differential
recruitment of transcriptional coactivators and
corepressors to produce its effect on MUC1 gene expression, and may
vary from
cell to cell. By examining the
mechanisms of PPAR action on MUC1 expression, we may be able to exploit
these
transcription factors as novel targets to reduce MUC1 overexpression in
breast
cancer. Funding provided by the Howard
Hughes Medical Institute Undergraduate Science Education Program, the
Ronald E.
McNair Scholars Program, and NIH grant HD29963. |
Cancer cells have the
extraordinary ability to alter their
phenotypes and mutate their genotype to attain selective advantage and
produce
one cell that will survive and colonize at the metastatic site. This is
a major
cause of treatment failure creating a tremendous hurdle to overcome in
designing novel cancer therapeutics. One alternate approach is to
examine the interactions
between drugs to determine if a previously undiscovered synergy exists.
This
would enhance tumor cell kill and increase the tolerance of the therapy
in the
patient by reducing the therapeutic dosage of both drugs. These drugs
are
chemosensitizers or cooperative chemotherapeutics. Adding drugs at the
IC20s
helps determine whether synergy with traditional chemotherapy occurs.
My
research involved obtaining inhibitory concentration curves for
different drugs
to determine the IC50, IC20 and IC10. Five drugs commonly used to treat
prostate cancer Docetaxel, Vinblastine, Cisplatine, Verapamil and
Etoposide,
were used in this research and two different assays, MTT and crystal
violet,
were applied to determine cell viability. LNCaP
cells were plated at 360,000 cells per 48 well plate
followed by
treatment with respective drugs for 5 or 7 days and the results were
analyzed.
To date we have obtained good dose-response curves for Docetaxel that
will
allow us to calculate the IC20 and begin synergy experiments with
sodium
channel blockers. Source of Funding: Department of Defense. |
Mutational Analysis of selected residues in the J-Domain and Hinge region of SV40 Large Tumor Antigen Krista Neal and Daniel T. Simmons Department of Biological Sciences Simian Virus
40 (SV40) provides an exemplary model system to study the highly
regulated
process of eukaryotic DNA replication. Its genome encodes the
multifunctional
protein, large T-Antigen (T-Ag), which orchestrates the initiation of
replication. T-Ag is known to interact with several cellular proteins
including
Replication Protein A (RPA), Topoisomerase I, and DNA polymerase
alpha/primase.
Topo I binds to double-stranded viral DNA ahead of the replication fork
and T-Antigen’s
helicase activity. It nicks one DNA strand, swivels it around, and
reanneals
the strands to release torsional strain generated in replication. Topo
I has
been found to interact specifically with T-Antigen double hexamers at
two
sites, one N-terminal and one C-terminal. Although these binding
domains are
approximated, they still remain to be defined. Prior data localized the
N-terminal
Topo I binding domain to T-Antigen’s J-Domain and adjacent Flexible
Linker
region. Single point mutations were generated in this region and
several mutant
proteins have been purified. In vitro replication assays are being
performed
with mutant T-Antigens to assess their ability to function in DNA
replication.
In addition, future assays will be performed to characterize the
ability of the
mutant T-Antigens to bind Topo I as well as to perform various
activities
involved in DNA replication. We hope to correlate replication
deficiency with a
Topo I binding deficiency in several mutant T-Antigens. Funded by the
HHMI
Program and PHS Grant from the National Cancer Institute. |
Apolipoprotein
C-I Production During Adipocyte Differentiation
Aivi Nguyen, Barbara Kwakye Safo, William Cain, David Usher Department of Biological Sciences One
apolipoprotein, apoE, appears to play a significant role in the
secretion
of unesterified cholesterol from adipoctyes. However, the Usher
lab has
identified another apolipoprotein, apoC-I, which may also be involved.
Previous
studies have shown that apoC-I mRNA is high in late-phase 3T3-L1
adipocyte
differentiation. Thus, in this study it is hypothesized that apoC-I is
both
synthesized and secreted by human and mouse adipocytes during
late-phase
differentiation. The hypothesis is to be tested
by differentiating
human and 3T3-L1 adipocytes under various conditions, and
correspondingly, utilizing
RT-PCR and western blots to quantify apoC-I mRNA and subsequent
expression,
respectively. However, to detect apoC-I in the supernatants or within
the
cells, specific antisera first had to be developed and tested for
specificity.
A series of immuno-dot and western blots on whole mouse plasma and
isolated
high density lipoproteins (HDLs) were conducted to characterize the
primary
antibodies to be used in the study. The immuno-dot blots
identified nine
different antisera capable of recognizing mouse apoplipoproteins in
mouse HDL.
Furthermore, Western Blot analysis of these antisera found
that eight were
capable of reacting with apoE and three for reacting with
apoC-I. For
detecting human apoC-I, an apoC-1 specific antisera was
commercially
purchased and tested. Funded by the
Howard Hughes Medical Institute.
|
The goals
of this research were i) to study bone cell viability in isolated bone
and ii)
to image the intracellular Ca2+ responses of the bone cells under
chemical and
mechanical stimuli. Living bone is capable of adapting its form and
mass to
meet its requirements of load carrying and calcium homeostasis. The
cellular
mechanisms of this bone adaptation have been extensively studied using
cultured
cells and the cells have been shown to respond to external mechanical
and
chemical stimuli by transient increase of intracellular Ca2+. Due to
technical
difficulties, experimental study of cellular responses in intact bone
has not
been undertaken yet. In this study, calvaria, tibia, femur and
metatarsals were
isolated from B6 mice in order to establish an organ model that allowed
for
imaging the levels of Ca2+ in situ. Cell viability was measured
using
the Live/Dead fluorescent assay and the intracellular Ca2+ was imaged
using the
ratiometric indicator, Fura-2. This research was sponsored by NIH. (P20
RR016458-06 A1) |
Small
Molecule Inhibitors of Macrophage Migration
Inhibitory Factor (MIF)
Tomasz Ociepa, James Pruitt, Thais Sielecki, Cytokine PharmaSciences, Elevated levels of Macrophage Migration Inhibitory Factor (MIF) have been implicated in a number of inflammatory disease states, including arthritis, multiple sclerosis, Crohn’s disease, and cancer. MIF activity can be inhibited through direct binding of MIF or through binding of the MIF receptor. Cytokine PharmaSciences has designed small molecules that inhibit MIF activity in vitro, and subsequently demonstrated that they have anti-MIF activity in vivo in several systemic, chronic animal disease models. These small molecules are orally bioavailable. This poster will introduce the target, outline the synthesis, and discuss preclinical data for Cytokine PharmaSciences Inc.’s MIF small molecule series. |
Tessa Reisinger1,
Ilsa Gómez-Curet2, Sarah
Swain1,
Vicky
Funanage2,3, Thomas O. Crawford4,
Mena Scavina2, Wenlan
Wang2,3
1Department of Biological Science, University of Delaware, Newark, DE; 2Nemours Biomedical Research, Alfred I. duPont Hospital for Children, Wilmington, DE; 3Department of Pediatrics, Thomas Jefferson University, Philadelphia, PA; 4Departments of Neurology and Pediatrics, Johns Hopkins University, Baltimore, MD Spinal
Muscular Atrophy (SMA) is an autosomal recessive
disease caused by mutation or deletion of the telomeric copy of the survival
motor neuron gene 1 (SMN1). The centromeric
copy of the gene, SMN2,
is present in all patients but unable to fully compensate for SMN1. SMN2
has a C→T transition in exon 7 that leads to exon skipping. As a
result, the
majority of transcripts from SMN2 gene lack exon 7.
Thus, SMA results
from insufficient levels of SMN protein in motor neurons. Although SMN1
is the disease-determining gene, the number of SMN2 copies appears to
modulate
SMA clinical phenotype. Determination of SMN copy number is
therefore
important for clinical diagnosis and prognosis. We have developed a
Multiplex
pyrosequencing assay that allows sensitive and quantitative
determination of
SMN copy number. This assay includes the cystic fibrosis
transmembrane
regulator
gene (CFTR) as an internal
standard of known copy number
(2 copies/genome). SMN and CFTR are amplified by
multiplex PCR
using gene-specific and universal primers to achieve equal
amplification
efficiency. The PCR sample is then run in a multiplex pyrosequencing
assay and
data is acquired as peaks in a pyrogram in which peak heights are
directly
proportional to nucleotide incorporation. SMN copy number is
determined by
comparing the peak height at the SNP site (C/T) in the SMN gene to the
peak height at one or more positions that are specific for the internal
standard CFTR. This assay was
validated with DNA samples of known SMN
copy number and will be used to determine SMN copy number of DNA
samples
isolated from SMA and control fibroblasts. The development of this
assay will
allow characterization of SMA cell lines and may also generate a
quantitative
assay that could be used for molecular diagnosis of SMA. Funding for
this
research has been provided by the Howard Hughes Medical Institute
Fellowship
and by grant support: Nemours and NIH 1 P20 RR020173-01.
|
Identification of Conserved Elements in Human Perlecan Promoter by Comparative Analysis with the Mouse Orthologue. Matthew Richards, Mary C. Farach-Carson, Benjamin Rohe Department of Biological Sciences Perlecan
is a heparan sulfate proteoglycan predominantly located in basement
membranes
and the matrix surrounding endothelial, mesenchymal and stromal cells. It is ubiquitously expressed in vascularized
tissue and the reactive stroma surrounding prostate cancer cell lines
produces
high levels of the protein. Additional
studies suggested that perlecan plays a role in delivery of growth and
angiogenic factors, which aids survival and growth of metastatic tumors. The overall goal of this project was to study
the promoter in order to understand the up-regulaton of perlecan in the
tumor
reactive stroma which occurs via transcriptional increases in perlecan
biosynthesis. Our first step was to
analyze the promoter to find conserved elements. The
sequence for the human perlecan promoter
was found using public databases and compared to a published human
sequence
(Iozzo et al., 1997) and a sequence for the mouse perlecan promoter
also found
in online databases. The promoters were
analyzed using MatInspector to identify potential consensus
transcription
factor binding sites. Data were compared to identify all conserved
elements. Potential binding sites of
interest were converted into promoter maps. Several
transcription factor binding sites of interest
were identified
for further study including NFkB, CREB, Smad3, Elk-1 and
TCF/LEF-1. Our next step is to prioritize
the pathways
to examine and perform QPCR analyses to test the effects of those
pathways on
the steady state levels of perlecan transcripts. Longer
term goals include building a
promoter-reporter construct with the perlecan promoter and testing the
pathways
to determine which exert transcriptional control via the functional
elements we
identified. This project was funded by
HHMI and NIH/ NCI P01 CA098912
|
Ritika Samant and Ulhas P. Naik Department of Biological Sciences A family of Junctional
Adhesion Molecules (JAMs) consisting
of JAM-A, JAM-B, and JAM-C has recently been discovered. These
molecules
are transmembrane proteins involved in tight junctions, which are often
associated with PDZ domain-containing proteins. JAM-A is known to
contain
a PDZ domain-binding motif, which it uses to interact with cytoplasmic
PDZ proteins.
Since there is significant conservation between JAM-A and JAM-B, we
believe
that JAM-B may also interact with PDZ domain-containing proteins.
To
study this, protein microarrays can be used to identify protein-protein
interactions between JAM-B and PDZ domain-containing proteins. A cDNA
construct
encoding for a polyhistidine-tagged JAM-B fusion protein using
polymerase chain
reaction (PCR) was first created. This construct will be used to
express
and purify protein, using affinity chromatography. The protein can then
be used
to probe a protein microarray spotted with PDZ domain-containing
proteins
functioning as capture molecules. Funding was provided by the
Beckman
Foundation and the NIH. |
Assessment of Candida albicans Ability to Mask b-Glucans from Dectin-1 Recognition Kevin E. Shuman1, Kirk Czymmek2, Liz Adams2 Dectin-1
is a glucan pattern recognition receptor (PRR) that is thought to play
a
pivotal role in the recognition of microorganisms that express glucans
in their
cell wall. Recent data suggests that Dectin-1 may be a sentinel PRR for
Candida albicans. Glucans are 1-3-b-D-linked
glucose polymers that form a major component of fungal cell walls of
fungal
cells and several bacteria. It has been suggested that pathogenic
microorganisms might be able to modify the glucan content of their cell
wall
surfaces to avoid immune recognition through Dectin-1. The purpose of
this
study was to examine 1) the effect of Candida
or Saccharomyces spores on the levels
of Dectin-1 expression and 2) corresponding binding forces between the
different
spores and Dectin-1 transfected cell line. Binding was investigated in
the presence
of different substrates (i.e. collagen I and IV, Fibronectin and an
uncoated
control plate) to determine their contribution to Dectin-1
upregulation.
Expression was also investigated in the presence or absence of LPS. LPS
is a
component of gram-negative bacterial cell walls and along with glucans
are
found to be released into the blood of patients with infections. We
employed a
transfected macrophage cell line (RAW264.7). Cells were infected with
either Candida albicans
(opportunistic
pathogenic species) or Saccharomyces cerevisiae
(non-pathogenic control species) for 3hrs at an infection
ratio of
1:10. Candida was seen to have a five
fold lower unbinding force than Saccharomyces
spores using AFM. Confocal images showed increased Dectin-1 expression
in the
presence of Saccharomyces spores
compared to Candida spores. This data
is consistence with the hypothesis that Candida
is able to modulate their Dectin expression levels to evade innate
immune
recognition. Supported by NIH grant 2 P20 RR016472-07 under the INBRE
Program of
the
|
Effects of RPL29 deficiency on bone structure and material properties Laura Sloofman1, Daniel S. Oristian1, Xiaozhou Zhou2, Liyun Wang2, and Catherine B. Kirn-Safran1 1Department of Biological Sciences and 2Department of Mechanical Engineering Ribosomal proteins (RPs)
play an important function in the
maintenance of a normal protein synthetic rate. Our
group generated the first viable mouse mutant model
lacking an
individual ribosomal protein. In these
mutants, the absence of RPL29 resulted in global skeletal growth
deficiencies
that persist during adulthood. In the
current study, we used RPL29 knockout mice to evaluate this protein
function in
bone structure and rigidity. We hypothesized that a decrease in protein
biosynthesis
affecting matrix production in RPL29 knockout mice reduces bone mass
and
increases bone fragility. The
bone microstructure of both null and wild type six-month-old femurs at
mid-shaft was assessed using micro-computed tomography (microCT).
Significant
differences in the bone composition were found between the null and
control
mice. We found that RPL29-deficient
femoral diaphyses exhibit a significant decrease in cortical area (11 %
and 19%
for males and females, respectively) and polar moment of inertia (39%
and 32%
for males and females, respectively) compared to control animals. Three-point bending tests were performed on
the femurs to determine the elastic modulus times the moment of inertia
(EI),
ultimate force, and stiffness. Interestingly,
only RPL29 null female femurs
showed significant reduction in their structural parameters when
compared to
controls. These data indicate that RPL29
deficiency is associated with decreased bone mechanical properties
specifically
in females. In conclusion, bone
structure and material properties in females appear to be more
sensitive to a
perturbation in global protein synthesis when compared to males. This project is supported by the |
In Vivo Short-term Effects of TiO2 Nanoparticles on Murine Sperm Michelle Smith, Chris Elder, Rowan Michael, Rolands Aravindan, and Patricia A. Martin-DeLeon Department of Biological Sciences |
To cleave and to uncleave: Expression of Heparan Sulfate modifying enzymes, Sulfatases and 6-O-Sulfotransferases during early pregnancy Pamela Sun1, Sonia S. D’Souza2, Catherine B. Kirn-Safran3, Daniel D. Carson3 1Imperial College School of Medine, 2Department of Chemistry and Biochemistry and Many growth factors play essential cell signaling roles during pregnancy and bind strongly to 6-O-sulfated motifs within heparan sulfate (HS) polysaccharides at the cell surface and in the extracellular matrix. Consequently, modulation of HS 6-O-sulfation is believed to control biological responses to these growth factors. Sulfatase-1 and Sulfatase-2 (Sulfs) are secreted endosulfatases that cleave the sulfate groups on the 6-O position of GlcNS residue of the HS proteoglycan in order to release the growth factors. Conversely, HS 6-O-Sulfotransferases (6HSOST1-3), encoded by three separate genes, add the sulfate at the same 6-O position of HS during its synthesis. Thus, the balance of Sulf and 6HSOST activities controls the HS-dependent cell signaling paradigm. This research project aims to determine which Sulfs and 6HSOSTs are expressed in the uterus during early pregnancy. Preliminary results obtained using conventional RT-PCR and real-time RT-PCR indicate an increase in mRNA production of both Sulf-1 and Sulf-2 in early pregnancy. Of these, Sulf-2 transcript is found to be more abundant. In addition, immunostaining with Sulf-2 antibodies demonstrated extracellular expression in the antimesometrial region of the decidua. Among the three 6HSOSTs, only 6HSOST-1 mRNA was detected in pregnant (day 8) mouse endometrium. In conclusion, both Sulfs and 6HSOST-1 are present in pregnant endometrium and are likely to play a significant role in controlling the HS-binding growth factor bioavailabilty during pregnancy. This project is supported by the |
Quantitative Analysis of Breast Cancer Metastasis to Brain Kathryn Teixeira and Deni S. Galileo Department of Biological Sciences Breast cancer is more
likely to metastasize to bones, lungs,
or the liver, but metastasis to the brain is particularly devastating,
and most
patients die shortly after diagnosis. Previously, human breast cancer
cells were
successfully injected into the extra-embryonic vasculature of chick
embryos,
and metastasis to the brain was documented and quantified. In order to
help
determine the mechanism of entry into the brain, the sensitivity of the
in vivo chick embryo system is being tested.
Five day old chick embryos were previously injected with 50,000
MDA-MB-231
cells which were transfected with the lacZ and neor genes.
Cancer
cells were recovered from dissociated brains several days later, and
re-cultured to form colonies in order to determine the percentage of
cancer
cells that migrated to the brain. I am injecting smaller numbers of
cells into the
blood vessels to find the minimum number of cells required for tumors
to
develop in the brain. I am also injecting other, non-tumorigenic cells
into
blood vessels in order to determine if known metastatic cells
preferentially
travel to brain. Additionally, I am injecting breast cancer cells
directly into
the brain to observe metastasis to other organs. Ultimately, these
results will
be used to investigate the effects of cell adhesion molecule L1 on the
rate of
metastasis of tumor cells into brain and elsewhere. L1 has been shown
to
increase cell migration velocity, and it is believed that cell lines
transfected with L1 will present higher rates of metastasis. Funding
for this
research provided by INBRE. |
Analysis of Mutated Mitochondrial DNA sequences in Prostate Cancer and Identification of microRNA through RNA Folding Mfon Umoren1, John Petros2, Department of Biological Sciences, Protein
biosynthesis is
influenced by the secondary structure of the coding RNA sequence, which can affect the
interactions
with RNA binding proteins, microRNAs and ribosomal entry. Secondary
structure
of RNA is defined by its sequence and the potential for interactions
between
the nucleotide bases in the RNA sequence which affect folding. Mutation
in the
RNA sequence can alter intramolecular interactions to create different
secondary structures that may predict function. RNA
folding software was used to determine the
significance of mutations
found in the mitochondrial DNA of prostate cancer patients. One
mutation was a
non-amino-acid changing sequence in the mtDNA section encoding
cytochrome c
oxidase II (COII). The second mutation was an amino-acid changing
sequence
found in the mtDNA encoding cytochrome b, altering leucine to proline.
We
folded and compared different lengths of the wild type sequence and the
mutated
sequence. Our hypothesis was that the non amino-acid changing mutation
would
cause a more significant change in the secondary structure of RNA than
would
the amino acid changing sequence. Analysis of folded RNA sequences also
was
used to identify possible microRNAs. MicroRNAs are short RNA sequences,
usually
21-23 nucleotides in length that are involved in the regulation of gene
expression. When folded, they form a distinct stem-loop structure. With
a group
of sequences that were either over- or under-expressed in cancerous
cells, RNA
folding and the presence of the stem-loop structure was used to
identify
potential miRNAs. Identification of possible miRNAs and further study
of their
targets will clarify their role in regulation of gene expression, as
well as
their role in cancer metastasis. Supported by the Department of
Defense. |
Effect of a novel BRCA2 variant found in a Curtis Warren, Center for Translational Cancer Research BRCA1 and BRCA2 mutations
are responsible for inherited
forms of breast cancer which account for some 5-10% of the disease. Patients at the |
Variations of Gene Repair in sub S-phase Cell Populations Melissa G. Warriner, Julia U. Engstrom, and Eric B. Kmiec Department of Biological Sciences and the Delaware Biotechnology Institute
Targeted
nucleotide exchange (TNE) relies on the use of a short synthetic
oligonucleotide (ODN) designed to be complementary to a target sequence
in the
genome except for a centrally located mismatch, which directs the
desired base
change in the DNA. The repair reaction
is believed to be enhanced by mechanisms that promote a more open
conformation
of the DNA, thus, enabling the target site to be more accessible for
the
binding of the oligonucleotide. One such
method is through the modulation of cell cycle progression to increase
the
population of cells in S phase, a point at which DNA is in a more open
structure. It has been established that
targeting cells in S phase leads to more probable integration events
than any
other phase of the cell cycle; this phenomenon is not only true for the
gene
repair reaction, where the aim is to direct the exchange of a single
base pair,
but also in many other systems, where the aim is to insert foreign DNA
into a
chromosome. However, it is still unclear
if this increase is due to a particular sub-S phase stage or simply S
phase as
a whole. Our work aims to discern
variations in repair levels in sub-phases of S as cells enter and
progress
through this phase. In addition, we
evaluate gene expression patterns of several cell cycle genes that may
help
denote the changes in cell cycle distribution as a function of gene
repair
events. Funded by Howard Hughes Medical
Institute. |
Chitin Induced Uptake of CTXΦ by Vibrio cholerae via Natural Transformation Coral Wille, Lynn M. Naughton, and E. Fidelma Boyd Department of Biological Sciences Vibrio
cholerae is a Gram-negative bacterium whose natural habitat is
the
marine environment. The marine habitat contains high amounts of chitin,
an insoluble polymer of β-1,4-linked N-acetylglucosamine, that is found
as a structural component of crab exoskeletons and copepod molts. V.
cholerae can degrade chitin for use as a carbon source. When
this
occurs, a 41 gene regulon is up-regulated, including genes involved in
colonization of chitin surfaces. Previously it was shown that V.
cholerae grown in the presence of chitin can naturally uptake
chromosomal DNA. In this study, we examined whether chitin could induce
natural competence in V. cholerae
strain 1528-79 to uptake the cholera
toxin encoding virus CTXΦ. The V.
cholerae 1528-79 recipient strain,
which is non-toxigenic, was mixed with plasmid DNA extracted from V.
cholerae strain O395, which contained CTXΦ marked with a
kanamycin
resistance gene. Transformed colonies were selected for on antibiotic
selective plates, and examined by PCR analysis. Successful
transformation of strain 1528-79 has important evolutionary
implications. The acquisition of new genetic material, CTXΦ, by natural
transformation demonstrates a novel mechanism for the emergence of new
toxigenic isolates. Research was funded by the Howard Hughes Medical
Institute.
|
Sperm
hyaluronidase activity is necessary for degradation of hyaluronan or
hyaluronic
acid (HA) in the extracellular matrix surrounding the oocyte in several
steps
in mammalian fertilization. These steps include the penetration of the
cumulus
oocyte complex, the zona pellucida, and the perivitelline space. To
date, the
only known human sperm hyaluronidase is Sperm Adhesion Molecule 1
(SPAM1 or
PH-20), a 64 kDa membrane protein which plays multifunctional roles in
mammalian fertilization and which has recently been shown to be a
marker of
sperm maturation in mice (Chen et al. 2006). SPAM1 is unique among the
hyaluronidases, with respect to its neutral hyaluronidase activity. Our
lab has
recently shown that a second sperm hyaluronidase, HYAL3, is present in
human
sperm. The objective of this study was to compare the levels of
hyaluronidase
activity in men using assisted reproductive technologies (ART) at
|
The interaction of microorganisms with quaternary ammonium compound-coated surfaces Stephanie Zilora1, Nina Lamba2, and Diane Herson1 1Department of Biological Sciences, Quaternary ammonium
compounds (QACs) are commonly used as
antimicrobial agents. This study uses
unique materials that have QACs covalently bonded to a polymer. The
QACs
maintain their antimicrobial activity when immobilized.
This allows them to be used in a broad range
of applications. For example, in a
hospital setting, there are numerous surfaces—such as curtains, bed
liners, and
trays—that could be made antimicrobial by use of this coating
technology in
order to provide infection control. In
addition, when bound to material, the QACs do not leach into the
environment,
which is a major advantage over both other solid phase antimicrobial
systems
and also aqueous antimicrobials. To
carry out the study, bacteria were incubated on QAC-coated glass slides
for varying
times at both room temperature and 37°C. Surviving
bacteria were enumerated using a viable cell
count
method. The QAC-coated slides exhibited
antimicrobial effects against both Gram-positive (Staphylococcus
aureus) and Gram-negative (Salmonella enterica)
organisms. The QAC coatings appear to be
more effective at higher
temperatures. Additionally, they are
more effective at lower concentrations of bacteria.
This project was generously funded by National
Science Foundation grant number 0450527 and a Charles Peter White
scholarship. |